St. Denis J. Villere & Co’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6M | Sell |
287,120
-1,707
| -0.6% | -$194K | 3.14% | 10 |
|
|
2025
Q1 | $30.4M | Buy |
288,827
+1,783
| +0.6% | +$187K | 2.93% | 13 |
|
|
2024
Q4 | $30.8M | Sell |
287,044
-187,814
| -40% | -$20.1M | 2.78% | 14 |
|
|
2024
Q3 | $47.5M | Sell |
474,858
-9,055
| -2% | -$906K | 3.88% | 3 |
|
|
2024
Q2 | $40.8M | Sell |
483,913
-6,839
| -1% | -$576K | 3.45% | 5 |
|
|
2024
Q1 | $35.9M | Buy |
490,752
+62,701
| +15% | +$4.58M | 2.86% | 13 |
|
|
2023
Q4 | $30.6M | Sell |
428,051
-10,110
| -2% | -$722K | 2.52% | 19 |
|
|
2023
Q3 | $26.3M | Sell |
438,161
-41,286
| -9% | -$2.47M | 2.24% | 23 |
|
|
2023
Q2 | $34.6M | Sell |
479,447
-1,360
| -0.3% | -$98.1K | 2.5% | 19 |
|
|
2023
Q1 | $35.4M | Sell |
480,807
-2,540
| -0.5% | -$187K | 2.57% | 17 |
|
|
2022
Q4 | $32.3M | Sell |
483,347
-303,898
| -39% | -$20.3M | 2.52% | 16 |
|
|
2022
Q3 | $42.3M | Sell |
787,245
-7,888
| -1% | -$424K | 3.37% | 9 |
|
|
2022
Q2 | $44.3M | Sell |
795,133
-23,748
| -3% | -$1.32M | 3.31% | 13 |
|
|
2022
Q1 | $57.5M | Sell |
818,881
-13,057
| -2% | -$916K | 3.41% | 14 |
|
|
2021
Q4 | $80.2M | Sell |
831,938
-72,713
| -8% | -$7.01M | 4.6% | 6 |
|
|
2021
Q3 | $78.6M | Sell |
904,651
-48,140
| -5% | -$4.18M | 4.58% | 2 |
|
|
2021
Q2 | $78M | Buy |
952,791
+91,935
| +11% | +$7.52M | 4.18% | 11 |
|
|
2021
Q1 | $81.9M | Sell |
860,856
-168,387
| -16% | -$16M | 4.48% | 9 |
|
|
2020
Q4 | $63.9M | Sell |
1,029,243
-34,160
| -3% | -$2.12M | 3.85% | 13 |
|
|
2020
Q3 | $63.2M | Buy |
1,063,403
+25,191
| +2% | +$1.5M | 4.25% | 11 |
|
|
2020
Q2 | $72.4M | Buy |
1,038,212
+19,092
| +2% | +$1.33M | 5.19% | 7 |
|
|
2020
Q1 | $46.2M | Buy |
+1,019,120
| New | +$46.2M | 3.94% | 9 |
|